Faris Farassati, PhD, PharmD
University of Minnesota
A Novel Strategy for Targeting Ovarian Cancer
Mesothelin is a plasma membrane antigen expressed in significantly high levels in mesothelioma and ovarian cancer patients. This study will test the hypothesis that ovarian cancer cells are biologically dependent on the expression of mesothelin for their survival. The results will provide a suitable basis for evaluating mesothelin silencing as a treatment strategy against ovarian cancer.